The share price of Biogen Inc. (NASDAQ:BIIB) tumbled as much as 8 percent, to $395, Friday after sales of the …
The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center are highlighting two trades on Biogen Idec (BIIB) today after it ... as long as the stock closes above $280 at expiration.
The Thomson/First Call consensus price target is $176.32. The stock closed Tuesday at $154.24. Biogen Idec Inc. (NASDAQ: BIIB) is another top stock to buy on Wall Street, and many predict that its Tysabri earnings will have a …
Sector Exposure and Top Holdings It is important to delve into an ETF's holdings before investing despite the many upsides to these kinds of funds like diversified exposure, which minimizes single stock risk. And, most ETFs are very …
Biogen Idec Inc. (NASDAQ: BIIB) was a big mover last session, as its shares rose over 11% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the …
Biotechnology stocks in general have been market leaders, at least until this week’s sharp pullback. Biogen (BIIB) remains a leading stock as evidenced from the strong bullish rally from the $300 per share December 2014 low to the overshoot …
By the way, Biogen (BIIB) , another Action Alerts PLUS holding ... In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private …
Biogen Idec Inc. (BIIB) was a big mover last session with shares rising over 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company …
Shares of Biogen closed the previous trading session at 276.44 up +2.58 0.94% with 274.3110046386719 shares trading hands. The post Insider Trading Activity Biogen (NASDAQ:BIIB) – Director Bought 48,000 shares of Stock appeared …
But short interest is still less than one percent of the float. Sixteen of the 26 analysts polled by Thomson/First Call rate the stock at Buy or Strong Buy. They believe the stock has a little room to run as the mean price target is about five …